SNPMiner Trials by Shray Alag

SNPMiner SNPMiner Trials (Home Page)

Report for Clinical Trial NCT03356548

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

Study of the Association Between Transferrin Saturation and Asthenia in Hemochromatosis

Observational study.

NCT03356548 Hemochromatoses, Genetic
MeSH:Hemochromatosis Asthenia

Primary Outcomes

Measure: Quality of life questionnaire SF 36

Time: Through study completion, an average of 3 months

Measure: Biological markers : Transferrin Saturation Coefficient

Time: Through study completion, an average of 3 months

Time Perspective: Prospective


There is one SNP


1 C282Y

- Inclusion criteria: - homozygous C282Y ; - in the maintenance phase for at least 6 months ; - follow-up at Rennes University Hospital ; - patient who has not expressed his opposition to participate in the study. --- C282Y ---

Hemochromatoses, Genetic Hemochromatosis Asthenia The linked HFE genetic hemochromatosis (C282Y mutation in the homozygous state) is the most common form of genetic iron overload. --- C282Y ---

Our objective is to evaluate, in patients homozygous C282Y in maintenance phase, the association between quality of life and Transferrin Saturation Coefficient . --- C282Y ---

HPO Nodes